CE
Healthcare & Life Sciences
Cellaïon
Belgium
Cellaïon is a Healthcare & Life Sciences startup based in Belgium, most recent round Series B, 1 tracked investor.
series-b
series-b
Stage
1
Investors
About Cellaïon
Based in Belgium, Cellaïon is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Cellaïon is a Walloon biotechnology company developing cell therapies for severe liver diseases, with its lead product HepaStem® in advanced clinical development for Acute-on-Chronic Liver Failure (ACLF) and a pipeline targeting acute toxic hepatitis, acute decompensation, and NASH.
Explore Cellaïon's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.